Showing results (301-310 of 441) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|January 3, 2018
Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordomaShuyu Hao, Hua Song, Wei Zhang, et al.Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.Acta Neuropathologica|February 22, 2015
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomasAdriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, et al.The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.Journal of Experimental & Clinical Cancer Research : CR|April 7, 2022
Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin IJing Cui, Jingcheng Zhou, Weiqing He, et al.Neuro-Oncology|January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survivalBenjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.JNCI Cancer Spectrum|March 28, 2025
Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping reviewAmanda L King, Tamara Vasilj, Diane Cooper, et al.Neuro-Oncology|March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignanciesMorris D Groves, Michael J Glantz, Marc C Chamberlain, et al.Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.Neurosurgery|April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesWilliam A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.Pageof 45